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Background: Type 2 diabetes mellitus (T2DM) is the most common chronic disease in the 
world. Macrovascular complications such as cardiovascular and cerebrovascular diseases 
can be detected early, one of them by using an ultrasound examination to assess carotid 
intima-media thickness (CIMT). HbA1c examination had a strong predictive value for the 
occurrence of T2DM complications. HbA1c levels are associated with CIMT in the non-DM 
group. In the T2DM group there was an increase in CIMT compared to the non DM group. 
HbA1c levels can be used as a predictor of the progression of CIMT improvement in the 
T2DM group, but there is no study on populations with newly diagnosed T2DM.  
Aims: This study was conducted to find out the correlation between HbA1c in newly 
diagnosed T2DM and CIMT. 
Methods: This was a cross-sectional study with correlation analysis carried out on newly 
diagnosed T2DM in four Primary Health Centers in the city of Bandung who were randomly 
selected from July to August 2018. HbA1c measurement was carried out at Dr. 
HasanSadikin hospital. The CIMT examination was done according to the Manheim 
Consensus by a cardiologist. Pearson correlation analysis was performed to assess the 
relationship between those two variables. 
Results: This study involved 32 subjects with a median age of 52 (40 - 60) years. The 
mean value of CIMT was 0.77±0.22 mm, while the median value of HbA1c was 6.7 (5.2-
12.3). Bivariate analysis showed a moderate positive correlation between HbA1c and CIMT 
in newly diagnosed patients with T2DM. (r= 0.567, p<0.001). 
Conclusion: There was a significant positive correlation between HbA1c in newly 
diagnosed T2DM and CIMT. 
 









Latar Belakang: Diabetes Melitus Tipe 2 (DMT2) merupakan penyakit kronis yang paling 
banyak ditemui di seluruh dunia. Komplikasi makrovaskular DMT2 berupa penyakit 
kardiovaskular dan serebrovaskular dapat dideteksi dini, salah satunya dengan 
menggunakan pemeriksaan USG untuk menilai carotid intima-media thickness (CIMT). 
Pemeriksaan HbA1c memiliki predictive value yang kuat untuk terjadinya komplikasi DMT2. 
Kadar HbA1c memiliki hubungan dengan CIMT pada kelompok non-DM. Pada kelompok 
DMT2 terdapat peningkatan CIMT dibandingkan dengan kelompok non-DM. Kadar HbA1c 
dapat digunakan sebagai prediktor progresi peningkatan CIMT pada kelompok DMT2,  
namun masih belum ada penelitian mengenai hal ini yang khusus pada populasi DMT2 yang 
baru terdiagnosis. 
Tujuan: Penelitian ini dilakukan untuk mengetahui hubungan HbA1c pada penyandang 
DMT2 yang baru terdiagnosis dengan CIMT. 
Metode: Penelitian ini merupakan penelitian potong lintang dengan analisis korelasi yang 
dilakukan pada penyandang DMT2 yang baru terdiagnosis penelitian dilakukan di empat 
puskesmas di kota Bandung yang terpilih secara acak pada bulan Juli sampai Agustus 
2018. Pengukuran kadar HbA1c dilakukan di laboratorium RSUP Dr. Hasan Sadikin. 
Pemeriksaan CIMT dilakukan menggunakan teknik yang sesuaidengan Konsensus 
Manheim oleh ahli jantung konsultan vaskular. Analisis korelasi Pearson dilakukan untuk 
menilai hubungan antara keduanya. 
Hasil: Penelitian ini melibatkan 32 subjek dengan median usia 52 (40 – 60) tahun. Nilai 
rata-rata CIMT sebesar 0.77+0.22 mm, sedangkan nilai median HbA1c adalah 6.7 (5.2– 
12.3). Analisis bivariat menunjukan korelasi positif sedang antara HbA1c pada penyandang 
DMT2 yang baru terdiagnosis dengan CIMT (r=0.567, p<0.001). 
Simpulan: Terdapat hubungan antara HbA1c pada penyandang DMT2 yang baru 
terdiagnosis dengan CIMT.  
  
INTRODUCTION 
Type 2 Diabetes Mellitus is the 
most prevalent non-communicable chronic 
disease, World Health Organization 
(WHO) data showed a marked increase of 
incidence from 108 million to 422 million 
cases from 1980 to 2014.1 The same 
dataset listed Indonesia as the fifth most 
numerous T2DM case.2 These numbers 
inherently showed that DM and its 
complications remains as the largest 
mortality contributor worldwide, with 
cardiovascular disease the most common 
cause of death in such population, 
accounting for half or approximately 4 
million annual deathsby the year 2017.2 
 Glycated hemoglobin or HbA1c 
has long been recommended by American 
Diabetes Association (ADA) as a 
diagnostic criteria for T2DM and its level 
determines glycemic control.3 HbA1c 
reflects the mean level of blood glucose 
within the last three months and has been 
proven to possess a strong predictive 
value for detecting T2DM complication.4  
 In retrospect, macrovascular 
complications in T2DM, that is 
cerebrovascular and cardiovascular 
diseases, are the main contributor in 
mortality and prompt the importance of 
early detection. One of the modalities that 
has long been proven for early 
macrovascular complication detection is 
ultrasonography for examining CIMT.5,6 
 Recent studies have elaborated 
the association between HbA1c and 
cardiovascular diseases.2 The increase in 
CIMT is a known marker for subclinical 
atherosclerosis. Conversely, HbA1c has 
also been discovered as independent 
predictor for the progression of CIMT 
increase in patients with longstanding 
T2DM. There is no data such relationship 
in newly diagnosed T2DM patients. 
 
METHODS 
 This is a cross sectional study 
aiming to analyze correlation on 32 
subjects of newly diagnosed T2DM in 
primary health facility in Bandung. We 
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conducted a consecutive sampling in July 
to August 2018 period. 
 Subjects eligible for enrollment 
were those who were newly diagnosed 
T2DM within under three months period, 
or over 6 months without routine 
medication in two consecutive months and 
aged under 60 years. We exclude those 
with anemia, history of blood transfusion 
within the last 3 months prior to 
enrollment, chronic kidney disease with 
GFR less than 60 mL/min, on medication 
affecting the measurements of HbA1c 
such as aspirin, opioid, antiretroviral, 
dapson, ribavirin, trimetoprim-
sulfamethoxazole, and hydroxyurea.  
 We conducted blood sampling and 
CIMT measurement to the subjects. 
Measurement of HbA1c was performed in 
HasanSadikin General Hospital central 
laboratory, and the CIMT measurement 
was taken by a vascular consultant 
according to Mannheim criteria. 
 Statistical analysis was performed 
using SPSS 21.0, (SPSS Inc, Chicago, IL, 
USA) We conducted Saphiro-Wilk for 
normality test, and then analyzed the data 
using Pearson’s method to investigate 
correlation. Baseline characteristics were 
presented using sum and percentage for 
categorical variables. Numerical data were 
presented based on the distribution 
normality; for normally distributed data, we 
use mean and standard deviation and for 
data with non-normal distribution, we 
present in median and range. A bivariate 
analysis was then performed to 
investigate correlation between HbA1c 
with CIMT using Pearson’s test for data 
with normal distributionor Rank-Spearman 
test for data with non-normal distribution. 
A p-value of <0.05 was considered 
statistically significant. We then further 
present the correlation coefficient for 
correlation coefficient (r) as in Table 3.2. 
and interrelation between HbA1c with 




 This study enrolled 32 subjects 
with baseline characteristics included age, 
gender, anthropometric parameters such 
as height, weight, body mass index (BMI), 
history of hypertension and blood 
pressure. 
Normality test shows that some 
baseline characteristics i.e. weight, BMI, 
and blood pressure did not have normal 
distribution, while others (gender, height, 
and BMI had normal distribution.  
 Baseline characteristics showed 
that most subjects were female (84.4%). 
Median age was 52 (40-60) years old. 
Other parameter anthropologic showed 
that more than half (53.1%) had normal 
weight, and mean BMI was 25.7 (17.3-
34.2) kg/m2. Almost one third (28.1%) of 
the subjects were hypertensive (table 1). 
 
Table 1. Baseline characteristics 
 
n=number; %=percentage; SD=standard deviation; * mean±SD; BMI=body mass index;  
Variables n=32 
Mean±SD Median (min-max) 
Age (years)  52 (40 – 60) 
Gender, n(%)   
     Male 5 (15.6)  
     Female 27 (84.4)  
Anthropometric parameters   
     Height (cm)* 153.0±7.0  
     Weight (kg)  59.5 (36.0 – 83.0) 
BMI (kg/m2)  25.7 (17.3 – 34.2) 
BMI classification, n (%)   
     Normoweight 17 (53.1)  
     Overweight 12 (37.5)  
     Obese 3 (9.4)  
Hypertension, n (%) 9 (28.1)  
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Table 2. HbA1C level and CIMT 
 
SD=standard deviation; * mean±SD 
HbA1C= Hemoglobin A1c; CIMT= Carotid intima-media thickness  
 
Table 3.Correlation analysisHbA1c level withCIMT 
 
 




95% CI p-value 
Determinant 
Coefficient (R2) 
Log HbA1c 0.567 0.279 – 0.755 <0.001 0.322 






Figures 1.Scatterplot showing correlation of HbA1C with CIMT 
 
Saphiro-Wilk normality test 
showed anormally distributed CIMT 
values, while HbA1c had non-normal 
distribution. The mean CIMT was 
0.77±0.22 mm, while the median HbA1c 
was 6.7 (5.2–12.3). 
Pearson correlation analysis 
showed that there was a moderate 
positive correlation between HbA1c (log 
transformation) with CIMT (r=0.567, 
p<0.001) (table 2). The scatter plot 
illustrated a positive linear trend between 
HbA1c with CIMT (figure 1). 
 
DISCUSSION 
 Baseline characteristics of the 
subjects showed a statistically significant 
gender difference (84.4% female vs. 
15.6% male). An epidemiological study by 
Forouhi et al.described that gender had no 
significance in T2DM prevalence.8 Both 
gender were found to have the same 
annual prevalence increment. The study 
result was similar to the data obtained by 
WHO regarding gender and T2DM 
prevalence.  
Known risk factors for T2DM were 
genetics, ethnicity, history of gestational 
diabetes, old age, abnormal BMI, 
imbalance dietary pattern, and physical 
inactivity. Framingham study had 
previously shown a similar risk between 
male and female propensity toward 
cardiovascular event, whereas Riskesdas 
2013 data stated that there were no 
statistically significant difference in T2DM 
Variables n=32 
Mean±SD Median (min-max) 
HbA1c (%)  6.7(5.2–12.3) 
CIMT  (mm) 0.77±0.22  
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incidence based on gender (1.7% for 
female vs 1.4 for male).9,10 
 The baseline BMI in this study 
showed a median of 25.7 (17.3-34.2) 
kg/m2. More than half (53.1%) had normal 
weight whereas 37.5% were overweight, 
and the other 9.4% were obese. This was 
opposed to WHO and IDF data, stating 
that the increase of prevalence of T2DM 
was in accord to the increase of abnormal 
BMI (obesity and overweight), and 
physical inactivity.2,11 The increase in fat 
mass in abnormal BMI, either obesity or 
overweight state, was shown to impair 
insulin activity on glucose storage and 
uptake to cellular level, and was termed 
insulin resistance.3,12 Study by Ernande et 
al., Zhang et al., Magdy et al,, and Leung 
et al. showed BMI abnormality with results 
of 29±5kg/m2, 25,2±3.1kg/m2, 29.13±3.14 
kg/m234±8 kg/,respectively.13-16 
 The prevalence of hypertension in 
this study was found at 28.1%. This was 
similar to the finding by Ernade et al 
(38%), but far lower than those of Nakai 
(78%), Zhang (48%), and Leung 
(69%).14.15,17-19. The meta-analysis by 
Colosia et al. and Kabakov et al. showed 
the hypertension prevalence of over 
50%.20,21 
 To our knowledge, there is 
currently no study investigating the 
correlation between CIMT and HbA1c in 
newly diagnosed T2DM patients. We 
found the HbA1c  median of 6.7 (5.2– 
12.3)%, and CIMT of 0.77±0.22 mm. 
Multiple studies by Kawamori et al., 
Geroulakos et al., and Mohan et al. 
showed that mean CIMT in diabetic 
patients were higher than non-diabetic 
patients.22-24  Other studies showed that 
mean CIMT in diabetic subjects was 
0.82±0.22 mm and 0.95±0.31 mm 
whereas in non-diabetic subjects were 
0.66±0.13 mm and 0.74±0.14 mm, 
respectively.21,24 Other studies by 
McnNeely et al., Hung et al., and 
Venkataraman et al. investigated the 
association between HbA1c with CIMT in 
nondiabetic subjects of various ethnicity 
shown a consistent relation between the 
increase of CIMT and HbA1c in.7,25,26 
 Study by Lee et al. toward elderly 
population (mean age 71.8 years-old) in 
Korea found that mean HbA1c was 5.5% 
and mean CIMT was 0.9 mm, 
demonstrating that HbA1c was 
independently associated with increase in 
CIMT ( (β=0,020, p=0,045).7 Multiethnic 
(whites, Asia-America, Afro-American, and 
Hispanic) study by McNeely et al. showed 
that a higher HbA1c (6±0.3%) compared 
to lower HbA1c (5±0.2%) correlates with 
higher CIMT values (0.87 vs. 0.85 mm, 
p=0.003) respectively.25 In T2DM patients, 
a cohort study by Yamasaki et al. in T2DM 
showed that at initial measurement, 
HbA1c was 8.66±0.1, with subsequent 
measurement after two-years follow-up 
was 8.15±0.08, revealed an increase in 
CIMT from initial measurement versus at 
two-years follow-up from 0.04±0.004 
mm/years. The study concluded that 
mean HbA1c was an independent 
progressivity predictor of two-years CIMT 
increase (p<0.001).28 
 As previously stated, this study 
was the first to investigate the relationship 
HbA1c and CIMT in newly diagnosed 
T2DM, resulting in a moderate positive 
correlation (r=0.567; p<0.001). We infer 
that the higher HbA1c, the higher the 
CIMT will be. The unknown duration of 
DM prior to diagnosis was the main 
weakness in this study. Theoretically, 
insulin resistance and hyperglycemia may 
have manifested far before T2DM was 
diagnosed, thus resulting in disease 
progressivity. This, in part, supports the 
previous study results regarding CIMT and 
HbA1c in either diabetic or non-diabetic 
patients.7,22-27. 
 The HbA1c as glycemic parameter 
indicates a chronic hyperglycemic state, 
and is utilized as primary complication 
predictor in diabetes based on study 
results and global diabetes guidelines. 
Hyperglycemia induces oxidative stress 
resulting in increased reactive oxygen 
species(ROS) formation and triggered cell 
injury mediated mainly through four 
molecular mechanisms.29-31 
 Hyperglycemia is also associated 
with the production of free fatty acids 
(FFA) and growth factors, leading to 
cellular metabolism abnormality. This will 
ultimately lead to endothelial and 
mitochondrial damage, producing ROS 
and disturbing genetic expression and 
nitric oxide production.30 Aside from insult 
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by hyperglycemia, endothelial dysfunction 
may result from multiple factors such as 
cigarette smoke exposure and abnormal 
lipid level.31  
These factors will increase 
endothelial ROS production that will 
interact with other intracellular molecular 
substances, and disrupting endothelial 
metabolic and synthetic function. 
Furthermore, endothelial dysfunction will 
trigger lipoprotein accumulation in intimal 
surface.  
These LDS particle will aggregate 
on thickening intimal surface rich in 
proteoglycans, signifying first signs of 
atherosclerosis.29-31 Multiple studies 
showed that glycemic parameters has 
positive correlation with oxidative stress. A 
high degree of DNA and oxidative stress 
were thought to occur in newly diagnosed 
T2DM patients as stated by the results of 
previous studies.36-38 Other study showed 
a statistically significant correlation 
between DNA damage with hyperglycemia 
and insulin resistance.3 
 The HbA1c and CIMT as glycemic 
parameters in this study were found to 
have moderate positive correlation 
(r=0.567; p<0.001) with determinant 
coefficient (R2) of 0.322. This means CIMT 
was affected by HbA1c to the extent of 
32.2%, and the remaining was affected by 
other factors.  
As stated in previous studies, 
CIMT is affected by various traditional risk 
factors namely, race, smoking, alcohol 
consumption, daily activity, dietary pattern, 
dyslipidemia, medications, hyperuricemia, 
and several novel risk factors such as 
inheritance, certain genotypes and 
anthropometric parameters, rheumatoid 
arthitis and other certain immunologic and 
inflammatory diseases, infection, vitamin 
D, matrix metalloproteinases, and many 
other under research factors.39.  
We admit that the weakness of this 
study is inability to measure and put into 
considerations of other factors affecting 
CIMT in T2DM patiens. 
 
CONCLUSION 
 There is a positive correlation 
between HbA1c level with CIMT in newly 
diagnosed T2DM patients. 
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